Related Experiment Video

Updated: May 26, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Peak serum: implications of serum supply for cell therapy manufacturing

David A Brindley1, Natasha L Davie, Emily J Culme-Seymour

  • 1The Advanced Centre for Biochemical Engineering, University College London, London, UK.

Regenerative Medicine
|December 16, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures
08:32

Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures

Published on: October 30, 2009

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers
09:44

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers

Published on: July 7, 2023

Related Experiment Videos

Last Updated: May 26, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures
08:32

Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures

Published on: October 30, 2009

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers
09:44

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers

Published on: July 7, 2023

Related Concept Videos

Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Articles linked to this work by shared authors, journal, and citation graph.

Solute transport through the glomerular filtration barrier: the podocyte slit diaphragms' role in maintaining glomerular basement membrane integrity and podocyte-to-endothelial crosstalk.

Tissue barriers·2026

Frequency, Burden and Pathogens of Acute Respiratory Illness in Very Preterm Infants During Infancy.

Acta paediatrica (Oslo, Norway : 1992)·2026

Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis.

Open forum infectious diseases·2025

Determinants of respiratory syncytial virus and human metapneumovirus transmission.

Clinical microbiology reviews·2025

Genetic diversity of Murray Valley encephalitis virus 1951-2020 identified via phylogenetic and evolutionary analyses.

PLoS neglected tropical diseases·2025

Applied Astrobiology: An Integrated Approach to the Future of Life in Space.

Astrobiology·2025

Combined umbilical cord-derived mesenchymal stem cell exosome and cell therapy in heart failure with reduced ejection fraction.

Regenerative medicine·2026

Industry updates in advanced therapy medicinal products and regenerative medicine - July 2026.

Regenerative medicine·2026

Bovine umbilical cord tissue‑derived MSCs and its conditioned medium promote the healing of excisional wound in rats.

Regenerative medicine·2026

Two-layered electrospun nanofibrous mat loaded chitosan nanoparticles, growth factors and hair follicle bulge stem cells can promote wound healing in rat.

Regenerative medicine·2026

Industry updates in advanced therapy medicinal products and regenerative medicine - June 2026.

Regenerative medicine·2026

Industry updates in advanced therapy medicinal products and regenerative medicine - May 2026.

Regenerative medicine·2026

Correction: Induced pluripotent stem cells as natural biofactories for exosomes carrying miR-199b-5p in the treatment of spinal cord injury.

Frontiers in pharmacology·2026

Repetitive transcranial magnetic stimulation: advances for psychiatric disorders.

Frontiers in psychiatry·2026

Advances in the clinical application of stellate ganglion block for non-pain indications.

Frontiers in medicine·2026

Correction: In-network multidisciplinary digital care improves outcomes in medicare advantage members with musculoskeletal diagnoses.

Frontiers in digital health·2026

Adaptation of the Yield-Scaling Factor to Reduce Target Yield Deviation and Donation Time in Pathogen-Reduced Apheresis Platelet Collections Using the Sysmex XN1000 Blood Bank Mode.

Annals of laboratory medicine·2026

The Trodden and Untrodden Path: Mentorship, Innovation, and Leadership in Dermatology.

Dermatologic clinics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us